These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35012825)

  • 21. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
    Veraldi S; Boneschi V; Cusini M; Maronese CA
    Dermatol Reports; 2023 Mar; 15(1):9503. PubMed ID: 37063394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
    McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
    J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
    Gökçek GE; Öksüm Solak E; Çölgeçen E
    Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
    [No Abstract]   [Full Text] [Related]  

  • 24. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
    Pedrazini MC; da Silva MH
    Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oropharyngeal lesions in pityriasis rosea.
    Ciccarese G; Broccolo F; Rebora A; Parodi A; Drago F
    J Am Acad Dermatol; 2017 Nov; 77(5):833-837.e4. PubMed ID: 28728872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pityriasis-rosea-like eruption following smallpox vaccination.
    WITHERSPOON FG; THIBODAUX DJ
    AMA Arch Derm; 1957 Jul; 76(1):109-10. PubMed ID: 13434484
    [No Abstract]   [Full Text] [Related]  

  • 27. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
    Cohen OG; Clark AK; Milbar H; Tarlow M
    Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pityriasis rosea during omalizumab treatment for chronic spontaneous urticaria.
    Vaccaro M; Marafioti I; Cannavò SP; Ciccarese G; Drago F
    Dermatol Ther; 2020 Nov; 33(6):e14356. PubMed ID: 33009684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
    Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
    J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
    [No Abstract]   [Full Text] [Related]  

  • 30. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
    Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
    Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
    Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical pityriasis rosea and Hodgkin's disease.
    Garcia-F-Villalta MJ; Hernández-Nuñez A; Córdoba S; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):81-2. PubMed ID: 14678538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
    Potestio L; Martora F; Cacciapuoti S; Megna M; Villani A; Ruggiero A
    Clin Cosmet Investig Dermatol; 2024; 17():51-57. PubMed ID: 38222859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review.
    Liu YA; Dai J; Nagarajan P; Torres-Cabala CA; Aung PP; Prieto VG; Cho WC
    Am J Dermatopathol; 2023 Mar; 45(3):185-188. PubMed ID: 36626570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pityriasis rosea developing after COVID-19 vaccination.
    Marcantonio-Santa Cruz OY; Vidal-Navarro A; Pesqué D; Giménez-Arnau AM; Pujol RM; Martin-Ezquerra G
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e721-e722. PubMed ID: 34237178
    [No Abstract]   [Full Text] [Related]  

  • 37. Pityriasis following COVID-19 vaccinations: a systematic review.
    Duzett L; Mercado G; Tasouli-Drakou V; Kane A; Tam A
    Dermatol Reports; 2024 Mar; 16(1):9742. PubMed ID: 38623364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea.
    Kosuge H; Tanaka-Taya K; Miyoshi H; Amo K; Harada R; Ebihara T; Kawahara Y; Yamanishi K; Nishikawa T
    Br J Dermatol; 2000 Oct; 143(4):795-8. PubMed ID: 11069458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral reactivation following COVID-19 vaccination: a review of the current literature.
    Martora F; Megna M; Battista T; Scalvenzi M; Villani A; Cacciapuoti S; Potestio L
    Clin Exp Dermatol; 2024 May; 49(6):556-565. PubMed ID: 38374769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pityriasis Rosea during Pregnancy: Major and Minor Alarming Signs.
    Drago F; Ciccarese G; Herzum A; Rebora A; Parodi A
    Dermatology; 2018; 234(1-2):31-36. PubMed ID: 29936509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.